HJC-0123
Product Specifications
Target
Apoptosis|||STAT|||Others|||Interleukin|||TGF-beta/Smad
Related Pathways
JAK/STAT signaling|||Apoptosis|||Immunology/Inflammation|||Others|||Stem Cells
Bioactivity
Downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values. Furthermore, HJC-0123 significantly suppressed estrogen receptor (ER) -negative breast cancer MDA-MB-231 xenograft tumor growth in vivo (p.o.), indicating its great potential as an efficacious and orally bioavailable drug candidate for human cancer therapy.
Smiles
C(NC=1C=C2C(=CC1)C=CS2(=O)=O)(=O)C=3C4=C(N=C(C3)C5=CC=CC=C5)C=CC=C4
Molecular Formula
C24H16N2O3S
Molecular Weight
412.46
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/86C6CCE1-D6C9-4781-8CBB-3202C7226783/T70686
CAS Number
1430420-02-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EK10373 48 Tests
Human Probable E3 ubiquitin-protein ligase HERC6 (HERC6) ELISA Kit
Ask
View Details 